Last reviewed · How we verify
Flolan®
At a glance
| Generic name | Flolan® |
|---|---|
| Sponsor | Actelion |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Hemodynamic Effects of Inhaled Iloprost in PH-COPD (HOLLYWOOD) (NA)
- ADAPT - A Patient Registry of the Real-world Use of Orenitram®
- Epoprostenol for Injection in Pulmonary Arterial Hypertension (PHASE4)
- LACunar Intervention (LACI-2) Trial-2 (PHASE2, PHASE3)
- Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH (PHASE4)
- Rapid Switch From Flolan to Remodulin in the Outpatient Clinic (PHASE4)
- Safety and Efficacy of Perioperative Remodulin® in Orthotopic Liver Transplant Recipients (PHASE2, PHASE3)
- Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |